Published in Ann Surg on November 01, 1975
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A rational approach to the surgical management of melanoma. Ann Surg (1977) 1.88
Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55
Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg (1991) 1.27
Prognostic value of tumour thickness in cutaneous malignant melanoma. J Clin Pathol (1983) 1.13
On the histological diagnosis and prognosis of malignant melanoma. J Clin Pathol (1980) 1.06
Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma. Arch Dermatol Res (1984) 1.01
Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. Br J Cancer (1995) 0.97
Current management of melanoma. Ann Surg (1977) 0.97
Nevoid malignant melanoma. Arch Dermatol Res (1985) 0.94
Pirin inhibits cellular senescence in melanocytic cells. Am J Pathol (2011) 0.92
Measuring melanomas: the Vernier method. J Clin Pathol (1984) 0.91
Assessment of biopsy techniques and histopathologic interpretations of primary cutaneous malignant melanoma. Ann Surg (1979) 0.91
Long-term survival analysis and clinical follow-up in acral lentiginous malignant melanoma undergoing sentinel lymph node biopsy in korean patients. Ann Dermatol (2014) 0.90
Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. Br J Cancer (1995) 0.90
Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.88
Treatment and outcomes of melanoma in acral location in Korean patients. Yonsei Med J (2010) 0.88
Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. Br J Cancer (1996) 0.87
The treatment of state I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg (1982) 0.86
Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int (2013) 0.85
Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia (1999) 0.84
Melanoma: what are the gaps in our knowledge. PLoS Med (2008) 0.84
Malignant melanoma of the eyelid skin: histopathology and behaviour. Br J Ophthalmol (1985) 0.83
Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management. Clin Exp Metastasis (2011) 0.82
Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma. Ann R Coll Surg Engl (1985) 0.82
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. Am J Pathol (1992) 0.80
Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy. Ann Surg (1979) 0.80
Separating melanin from hemodynamics in nevi using multimode hyperspectral dermoscopy and spatial frequency domain spectroscopy. J Biomed Opt (2016) 0.78
Cutaneous melanoma of the breast. Ann Surg (1979) 0.77
Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg (1985) 0.77
Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma. Cancer Biother Radiopharm (2014) 0.77
Cutaneous malignant melanoma in West Yorkshire: II. A prospective study of recurrence and prediction of lymph nodal metastasis. Br J Cancer (1984) 0.76
Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann Surg (1978) 0.76
Strategy in the management of melanoma. Proc R Soc Med (1977) 0.75
Tumor thickness. Ann Surg (1995) 0.75
Cutaneous malignant melanoma. Can Fam Physician (1985) 0.75
Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion. Ann Surg (1980) 0.75
Melanoma in black patients. J Natl Med Assoc (1982) 0.75
First experiences with a high-resolution ultrasonic scanner in the diagnosis of malignant melanomas. Arch Dermatol Res (1983) 0.75
Plastic surgery: treatment of melanoma. West J Med (1976) 0.75
Study of the histopathological types of cutaneous melanoma in Palmas-TO from 2001 to 2011. An Bras Dermatol (2015) 0.75
Metastasis in cutaneous melanoma. Ann Surg (1977) 0.75
Tumor thickness as a prognostic guide to melanoma. Ann Surg (1981) 0.75
The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg (1970) 12.72
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck. Am J Surg (1974) 2.33
Prognostic significance of lymph node dissection in the treatment of malignant melanoma. Cancer (1970) 2.08
Treatment of malignant melanoma: wide excision alone vs lymphadenectomy. Arch Surg (1972) 1.66
Prognostic factors in cutaneous malignant melanoma. A comparative study of long term and short term survivors. Hum Pathol (1974) 1.40
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg (1970) 12.72
Evaluation of prognosis in Stage I cutaneous melanoma. Plast Reconstr Surg (1978) 2.47
Stage I melanoma of the limbs: assessment of prognosis by levels of invasion and maximum thickness. Tumori (1978) 2.46
Optimal size of resection margin for thin cutaneous melanoma. Surg Gynecol Obstet (1977) 1.53
Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol (1979) 1.17
Lymphosarcoma and sarcoidosis. Am Rev Respir Dis (1967) 1.05
Prognosis in cutaneous melanoma: tumor thickness as a guide to treatment. Pathol Annu (1980) 0.98
Problems in the measurement of tumor thickness and level of invasion in cutaneous melanoma. Hum Pathol (1977) 0.84
In search of thin lethal melanomas. Surg Gynecol Obstet (1976) 0.84
The effect of surgery on the concentration of circulating megakaryocytes and platelets. Blood (1968) 0.82
The surgical treatment of stage I cutaneous melanoma. Cancer Treat Rev (1978) 0.81
Intracellular mucin production by lobular breast carcinoma cells. Arch Pathol Lab Med (1976) 0.79
Ultrastructure of myofibroblasts and decidualized cells in leiomyomatosis peritonealis disseminata. Am J Clin Pathol (1979) 0.77
Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann Surg (1978) 0.76
Metastasis in cutaneous melanoma. Ann Surg (1977) 0.75
Measurements of tumor thickness. Hum Pathol (1978) 0.75
Melanoma thickness and elective node dissection. Arch Dermatol (1978) 0.75
Opportunistic pathogens in the immunologically hyperresponsive host. Pneumocystic carinii infection in a patient with allergic bronchopulmonary aspergillosis. Am J Med (1973) 0.75
Metastasis from primary cutaneous malignant melanomas. Am J Dermatopathol (1979) 0.75
Chronic knee pain in a 35-year-old man. Invest Radiol (1981) 0.75
Tuberous sclerosis in the newborn. Am J Dis Child (1966) 0.75
Pulmonary blastoma. Am Rev Respir Dis (1973) 0.75
Malignant melanoma: correlation of long-term follow-up with clinical staging, level of invasion and thickness of the primary tumor. Am Surg (1977) 0.75
Occult carcinoma of second breast following mastectomy. JAMA (1973) 0.75
Surgical pros and cons. The debate over immediate lymph node dissection in melanoma. Surg Gynecol Obstet (1979) 0.75